Login
Toggle navigation
Videos
Categories
Trending
HERNAN CHIESSA - Head of Press and Communications at Metrogas, discusses warnings on the use of... Federico Barni, CEO of Bumeran, participates.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tomas Cordoba - CEO - MetroGAS
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Griffin Gold Corporation: Advancing Mining Prospects in Nevada's Walker Lane Gold Belt
00:10:00
Ornella and J. Bradley Hall, CEO of Icon Capital Reserve, discuss innovative developments at the forefront of finance and technology.
00:10:00
Fostering Societal Contribution Beyond Profit: A Call for Wildlife Conservation |Harald Link, CEO, B Grimm Power PCL.
00:10:00
BRASTER S.A mission is to create a healthier world|Dariusz Karolak, President, BRASTER S.A.
00:10:00
Eurizon's Dedication to Sustainable Asset Management | Saverio Perissinotto ,President, Eurizon Capital.
00:10:00
Dr. David Hampton, Executive Director, Lisk Indianapolis
00:10:00
"Designing the Workplace of Tomorrow: Insights from Simi Dubb, Global Head of Talent Management at Fidelity International"
00:10:00
Discovering New Perspectives in ETFs and Financial Innovation | Jenny Johnsons, Chief Executive Officer , Franklin Templeton .
00:10:00
Strategic Challenges and Opportunities in the Merged Asset Management Company
00:10:00
Navigating ESOP Transactions: The Importance of Managerial Support and Data Management
00:10:00
Barton Gold: Driving Growth with Efficient Resource Expansion and Asset Monetization
00:10:00
Magdalena Dziczek from EKO PAK participates in the TOGETAIR 2022 event focusing on hot seats and discussions on sustainability.